AngioDynamics, Inc. (FRA:UG2)

AngioDynamics Statistics

Total Valuation

AngioDynamics has a market cap or net worth of EUR 460.01 million. The enterprise value is 434.93 million.

Market Cap	460.01M
Enterprise Value	434.93M

Important Dates

The next estimated earnings date is Tuesday, January 6, 2026.

Earnings Date	Jan 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	41.20M
Shares Outstanding	n/a
Shares Change (YoY)	+1.49%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	3.56%
Owned by Institutions (%)	80.21%
Float	33.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.79
PB Ratio	3.01
P/TBV Ratio	4.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.85
EV / Sales	1.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.90

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.05.

Current Ratio	2.29
Quick Ratio	1.19
Debt / Equity	0.05
Debt / EBITDA	9.82
Debt / FCF	-0.55
Interest Coverage	-5,811.57

Financial Efficiency

Return on equity (ROE) is -17.10% and return on invested capital (ROIC) is -7.44%.

Return on Equity (ROE)	-17.10%
Return on Assets (ROA)	-5.20%
Return on Invested Capital (ROIC)	-7.44%
Return on Capital Employed (ROCE)	-11.78%
Revenue Per Employee	380,865
Profits Per Employee	-40,653
Employee Count	675
Asset Turnover	1.08
Inventory Turnover	2.17

Taxes

Income Tax	-91,474
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+64.06%
50-Day Moving Average	10.02
200-Day Moving Average	8.78
Relative Strength Index (RSI)	55.09
Average Volume (20 Days)	84

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.28

Income Statement

In the last 12 months, AngioDynamics had revenue of EUR 257.08 million and -27.44 million in losses. Loss per share was -0.67.

Revenue	257.08M
Gross Profit	139.21M
Operating Income	-19.88M
Pretax Income	-27.53M
Net Income	-27.44M
EBITDA	-1.38M
EBIT	-19.88M
Loss Per Share	-0.67

Balance Sheet

The company has 33.14 million in cash and 8.21 million in debt, giving a net cash position of 24.93 million.

Cash & Cash Equivalents	33.14M
Total Debt	8.21M
Net Cash	24.93M
Net Cash Per Share	n/a
Equity (Book Value)	152.90M
Book Value Per Share	3.69
Working Capital	75.55M

Cash Flow

In the last 12 months, operating cash flow was -6.66 million and capital expenditures -8.39 million, giving a free cash flow of -15.05 million.

Operating Cash Flow	-6.66M
Capital Expenditures	-8.39M
Free Cash Flow	-15.05M
FCF Per Share	n/a

Margins

Gross margin is 54.15%, with operating and profit margins of -7.73% and -10.67%.

Gross Margin	54.15%
Operating Margin	-7.73%
Pretax Margin	-10.71%
Profit Margin	-10.67%
EBITDA Margin	-0.54%
EBIT Margin	-7.73%
FCF Margin	n/a

Dividends & Yields

AngioDynamics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.49%
Shareholder Yield	-1.49%
Earnings Yield	-5.97%
FCF Yield	-3.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AngioDynamics has an Altman Z-Score of 1.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.46
Piotroski F-Score	4